Previous Article | Next Article 
Molecular and Cellular Biology, August 2001, p. 5658-5666, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5658-5666.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Gene Targeting Reveals a Crucial Role for
MTG8 in the Gut
Franco
Calabi,1,*
Richard
Pannell,2 and
Gordana
Pavloska1
Institute of Child Health, London WCIN
1EH,1 and MRC Laboratory of Molecular
Biology, Cambridge CB2 2QH,2 United Kingdom
Received 7 February 2001/Returned for modification 2 April
2001/Accepted 23 May 2001
 |
ABSTRACT |
The MTG8 (ETO) locus is involved in a
reciprocal exchange with runx1 in the t(8;21) of acute
myeloid leukemia. It is a member of a small gene family encoding
transcriptional regulators that interact with corepressors and histone
deacetylase. However, the physiologic cellular processes controlled by
MTG8 are not known. In order to gain an insight into the
latter, we have generated mutant mice with an insertional inactivation
at the locus, which disrupts transcription of exon 2. The postnatal
viability of homozygous mutants was greatly reduced. In approximately
25% the midgut was missing, whereas practically all pups surviving
past the first 2 days showed severe growth impairment, which was likely
due to a gross disruption of the gut architecture. The latter phenotype could be traced back to late embryonic development. No difference in
gut cell differentiation or proliferation was found compared to
wild-type littermates. Levels of factors known to be involved in gut
morphogenesis were also unchanged. MTG8 is expressed in the
outermost layers of the developing gut from at least E9.5. Thus,
MTG8 plays a novel, essential role in the gastrointestinal system.
 |
INTRODUCTION |
The study of tumor-associated
chromosomal translocations has led to the identification of genes that
play a key role in controlling cell growth and differentiation
(26). In the t(8;21) of acute myeloid leukemia (AML),
early work showed the breakpoints to fall within the coding sequence of
two previously unknown genes, runx1 at 21q22 (previously
named AML1/CBFA2) (21) and MTG8 at
8q22 (also named ETO/CDR) (20). The former is
related to the runt gene of Drosophila
melanogaster and, together with it, defines a novel family of
DNA-binding transcription factors (14, 33). Mouse
runx1 has been shown to be essential for definitive
hemopoiesis (23, 37) and haploinsufficiency at
runx1 in humans is associated with diserythropoiesis and an
increased risk of AML (32). Another runx member
(runx2) is essential for osteogenesis in mammals, as shown
both by gene targeting (16, 24) and by its mutations in
cases of human cleidocranial dysplasia (22).
Relatively little is known about MTG8/ETO. It belongs to a
small, phylogenetically conserved family, consisting of three members in humans and mice (4, 7, 10, 15) and one member in D. melanogaster (9). The latter
(nervy) was identified as a target of the homeotic gene
Ubx, and its expression in embryogenesis is largely
restricted to precursors of the central and peripheral nervous system.
However, there is no known phenotype associated with its mutations.
Sequence comparison has identified four regions conserved among all
MTG8-like polypeptides (4, 15). The COOH-terminal of these
(NHR4, for nervy homology region 4) has the potential to fold as a
double zinc finger, although it does not bind DNA (F. Calabi,
unpublished results). The most NH2-proximal region (NHR1)
is related to TAFII, a class of molecules involved in
transcription initiation by RNA polymerase II (1). The
notion that MTG8 is implicated in gene transcription is
strengthened by two additional observations: first, MTG8 products are
primarily localized to the nucleus (7, 8, 18) and, second,
they interact with corepressors such as N-CoR and mSin3, leading to the
recruitment of histone deacetylase to the transcription complex
(11, 19, 36). Based on Northern blotting analysis,
MTG8 in the adult is expressed mainly in the central nervous
system, lungs, heart, and testis (20, 40). However, the
cellular functions in which MTG8 is involved are not known.
In order to gain an insight into the latter, we have introduced a
targeted mutation at the mouse MTG8 locus. Its phenotype reveals a crucial role in the gastrointestinal system.
 |
MATERIALS AND METHODS |
Gene targeting.
A mouse genomic library from strain 129/Sv
in phage
2001 (38) was screened with an MTG8
probe spanning exons 2 to 4 (Table 1).
Two overlapping clones (
ESMM5 and
ESMM9) were chosen for further
manipulations. A targeting vector was assembled in pUC18, by subcloning
an ~1.5-kb partial BglII/SstI fragment from
ESMM5 spanning most of exon 2, and an ~7-kb SstI
fragment from
ESMM9 spanning exon 3. An Escherichia coli
lacZ gene (from the KpnI site at nucleotide (nt) 624 to
the XbaI site at nt 4158 in plasmid pSV-
-galactosidase
[Promega]) was inserted, after blunting, at the internal
SstI site, giving an in-frame fusion to exon 2. A 1.1-kb
fragment encoding the neor gene (from a modified
pMC1neo PolyA vector [34]) was inserted at the
BamHI site at the 3' end of the lacZ gene, and a
2-kb fragment encoding the herpes simplex virus tk gene
(38) was inserted at the 3' end of the mouse sequence
(with respect to the MTG8 transcriptional orientation).
The SalI-linearized vector was transfected into CCB ES cells
by electroporation as previously described (38). G418 and
gangciclovir double-resistant clones were screened by Southern blotting
using a 5' flanking probe (a 0.3-kb PstI fragment, mapping
~1.5 kb upstream of the region used to assemble the vector; Fig. 1A).
Clones giving the expected pattern were further analyzed using a 3'
probe (a 0.6-kb RsaI/XbaI fragment mapping
~5-kb downstream of the region used to assemble the vector; Fig. 1A)
and a neo probe (the whole 1.1-kb fragment used for vector
construction) to confirm single integration. Two clones were injected
into C57BL/6 blastocysts, one of which (MTG8-lacZ222) yielded a high
degree of chimerism and germ line transmission. Chimeras were
backcrossed to C57BL/6, and further generations were produced by interbreeding.
Histological analysis.
Organ samples were removed
immediately following sacrifice and fixed either in buffered formalin
or in Bouin's solution overnight at room temperature, prior to
embedding in paraffin and sectioning at 4 to 6 µm.
Staining with hematoxylin and eosin, or Alcian blue was performed
according to standard protocols. For immunohistochemistry, the
following monoclonal antibodies were used as primary reagents: anti-PCNA (clone sc-56 [Santa Cruz Biotechnology], 1 µg/ml),
anti-human sucrase-isomaltase (clone MGlu2 [12], culture
supernatant diluted 1:64), anti-
smooth muscle actin (clone 1A4
[Sigma], ascitic fluid diluted 1:800), and anti-
tubulin III
(clone SDL.3D10 [Sigma], ascitic fluid diluted 1:1,600). A
biotinylated horse anti-mouse immunoglobulin G (Vector Laboratories,
7.5 µg/ml) was used as a secondary reagent. Biotinylated Ulex
europaeus agglutinin I (UEAI) lectin was purchased from Vector
Laboratories and used at 7.5 µg/ml. Sections were deparaffinized,
rehydrated, treated with 3% H2O2 in methanol
for 10 min, heated to 95°C in a microwave oven for 10 min, and
blocked in 10% horse serum in phosphate-buffered saline (PBS) for 30 min. Antibodies were diluted in 10% horse serum in PBS and incubated
for 30 to 60 min at room temperature. The results were visualized with
the Vectastain Elite kit (Vector Laboratories), using diaminobenzidine
as the substrate, following the manufacturer's instructions. Sections
were lightly counterstained with Gill's hematoxylin.
Embryos were fixed in 4% paraformaldehyde in PBS for 3 to 12 h
and stained with X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) according to a
published protocol (29) prior to embedding and sectioning
as described above. Sections were counterstained with eosin.
RNA analysis.
Total RNA was extracted from fresh tissues by
the guanidine-acid phenol method (6). For gene expression
studies, probes (Table 1) were prepared by PCR amplification from mouse
genomic DNA, cloned in M13 phage, and sequenced to confirm their identity.
High-specific activity, single-stranded DNA probes were prepared
according to standard procedures (28). Ca. 5 × 104 cpm were mixed with ~20 µg of total RNA in 20 µl
of 50% formamide-0.5 M NaCl-1 mM Na2EDTA-25 mM PIPES
(pH 6.8), heated at 50°C for 30 min, and then left to hybridize at
45°C for ~18 h. S1 digestion was with 25 U for 30 min at 37°C.
Western blotting analysis.
Tissue extracts were prepared by
homogenizing fresh organs in 10 volumes of 10% sodium dodecyl sulfate
(SDS)-10 mM EDTA-25 mM Tris-Cl (pH 6.8) using an Ultra-Turrax
homogenizer (IKA). Approximately 150 µg of total protein was
fractionated by SDS-polyacrylamide gel electrophoresis on 7.5% gels
and electroblotted onto polyvinylidene difluoride membranes (Hybond-P;
Amersham Pharmacia Biotech) in 192 mM glycine-25 mM Tris-20%
methanol at 125 V for 2 h. Blots were probed with a rabbit polyclonal
antiserum raised against the C-terminal 212 amino acids of MTG8 (PC283;
Oncogene Research Products; final concentration, 2.5 µg/ml), followed
by horseradish peroxidase-coupled anti-rabbit antiserum (Amersham
Pharmacia Biotech; 1:40,000), and developed using the ECL-Plus system
(Amersham Pharmacia Biotech).
 |
RESULTS |
Gene targeting of mouse MTG8.
The human
MTG8 locus consists of at least 13 exons spanning >87 kb
(40; F.C., unpublished). We chose to target exon 2, since it represents the common splice acceptor for a number of alternative upstream exons (20; F. Calabi, unpublished data), and it
is the exon to which 5' runx1 sequences are most frequently
spliced in transcripts deriving from the t(8;21) (30, 35).
Mouse genomic clones containing MTG8 exons 2 and 3 were
isolated from an 129/Sv library. An E. coli lacZ coding
sequence was inserted in frame in place of the 3' end of exon 2 and of
the adjoining intron, in order simultaneously to disrupt
MTG8 transcription and to enable tracking of exon 2 expression by assaying for
-galactosidase activity.
neor and tk cassettes were further
inserted in order to allow selection of homologous recombinants
according to a standard strategy. The structure of the resulting
targeted allele, MTG8Ex2/lacZ, is illustrated in
Fig. 1A.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Generation and expression of the
MTG8Ex2/lacZ allele. (A) Diagram of the wt
locus, the targeting vector and the mutant locus. Thick black line and
boxes, murine MTG8; white box, lacZ; dark gray
box, neor gene; light gray box, tk
gene; thick striped lines, promoters (arrows indicate transcriptional
starts) and 3' UTR [lollipop symbols indicate poly(A) signals]; thin
line, pUC18. The 5' and 3' bars indicate the positions of the probes
flanking the targeted region and used in the Southern analysis. Relevant restriction sites are
represented by capital letters (B, BamHI; H,
HindIII; S, SstI, Sl, SalI). (B)
Southern blotting analysis of wt (+/+) and
MTG8Ex2/lacZ-targeted (+/ ) CCB ES cells.
Restriction enzymes are as in panel A. The probes are described in
Materials and Methods. The numbers on the left indicate the molecular
size markers in kilobase pairs. (C) S1 protection analysis of brain RNA
from wt (+/+) and MTG8 exon 2-null ( / ) pups with a probe
spanning MTG8 exons 2 to 4 (Table 1). tRNA, negative control
for probe hybridization. The top band corresponds to residual
undigested full-length probe. The double filled arrows point to the
band resulting from full protection of MTG8 sequences; the
single filled arrow points to the band resulting from protection of
exons 3 and 4 only. For reference purposes, protection by an actin
probe added to the same hybridization mixture is shown at the bottom
(single open arrow). The numbers on the left indicate the molecular
size markers in nucleotides. (D) Western blotting analysis of brain
from wt (+/+) and MTG8 exon 2-null ( / ) mice with an
antiserum against the C-terminal domain of MTG8. No bands were visible
with normal rabbit serum (data not shown). Asterisks mark species that
are absent in the mutant. The numbers on the right indicate the
molecular size markers in kilodaltons.
|
|
Following electroporation in CCB ES cells, screening of 230 G418 plus
gangciclovir double resistant clones by Southern blotting yielded three
homologous recombinants. Only one, however, gave chimeras when injected
into C57BL/6 blastocysts. Detailed genomic analysis of this clone by
Southern blotting with probes flanking either end of the targeting
vector, as well as for the inserted neor gene
(Fig. 1B), confirmed correct and unique integration of the mutation.
The effect of the introduced mutation on MTG8 expression was
investigated both at the RNA and at the protein level in extracts from
brain, where the highest levels of MTG8 mRNA are found (20, 40). In nuclease protection experiments with a cDNA probe, a protected fragment corresponding to spliced exons 2 to 4 and
representing the major species in the wild type (wt) is completely
absent in the mutant (Fig. 1C). However, a fragment corresponding to
alternative splicing upstream of exon 3, which is barely visible in the
wt, is substantially increased in the mutant. Consistent with this result, a 3' untranslated region (UTR) probe gives a comparable signal
in both the mutant and the wt (data not shown).
On Western blotting analysis with an antiserum directed against the
C-terminal domain of MTG8, two species of ca. 75 and 90 kDa are absent
in the mutant, whereas a smaller species of ca. 55 kDa is increased,
and a much larger polypeptide of >200 kDa is unchanged (Fig. 1D). The
size of the two former polypeptides is consistent with that reported in
human cell lines (8), whereas the other species must
either result from alternative splicing or correspond to cross-reacting
MTG8 paralogues. Altogether, the data confirm that the
MTG8Ex2/lacZ mutation prevents the synthesis of
wt MTG8 products carrying exon 2-encoded sequences.
Reduced viability of MTG8 exon 2-targeted mice.
The viability and fertility of MTG8Ex2/lacZ
heterozygous mice were essentially identical to those of wt controls.
Upon mating, heterozygous mice gave birth to the three expected
genotypes in Mendelian ratios. However, postnatal viability of
homozygous mutant pups was greatly reduced (Fig.
2A). Moreover, nearly all of those that
survived past the first 2 days showed significantly reduced size and
usually died before reaching puberty. Of the few adults, females were fertile, despite the reduced size, while no progeny were ever obtained
from the males, despite successful mating, as judged by the formation
of a vaginal plug.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Viability of the offspring from crosses between
MTG8Ex2/lacZ heterozygous mice. The cumulative
percent survival over the first 2 weeks after birth of 153 newborn pups
representing all accounted offspring of 17 matings is shown. All five
MTG8 exon 2-targeted homozygous mice surviving past day 15 were severely growth retarded. (B) Midgut phenotype. An in situ view
following sacrifice of a P0 homozygous mutant pup is shown. The defect
extends from the distal portion of the duodenum to the rectum. The
duodenal end is covered by an outgrowth of the mucosa, the rectal stump
is surrounded by a prominent vascular network and the residual
mesentery is hypervascularized. du, duodenum; ki, kidney; me,
mesentery; re, rectum. (C) Abnormal gut structure in growth-impaired,
MTG8 exon 2-targeted mice. A low-power view of hematoxylin
and eosin-stained jejunal sections from mutant ( / ) and control
(+/+) P29 mice is shown. Note in the mutant the reduction in gut wall
thickness due primarily to disorganization of the villi; note also the
dilation of the lumen.
|
|
Absence of the midgut in MTG8 exon 2-targeted
mice.
While there was no significant difference in size and
general appearance among P0/P1 pups born of
heterozygous crosses, a fraction showed a distinctive pallor and no
milk in their stomach. Upon sacrifice, these pups revealed a striking
phenotype, consisting in the absence of most of the intestine, spanning
from the distal duodenum to the greater part of the colon (Fig. 2B).
The missing segments largely correspond to the districts supplied by
the superior mesenteric artery, i.e., the midgut. On this basis, we
operationally refer to this phenotype as
midgut (i.e., deletion of
the midgut). It was never observed past P1, likely causing
early postnatal death.
Of the residual intestinal segments, the proximal (duodenal) stump was
pervious and showed an outgrowth of the mucosa, with villi projecting
into the peritoneal cavity. The distal (rectal) stump was blind ended.
On histopathological analysis, neither segment showed any significant
anomaly, with the exception of a dilated vascular network, more
prominent over the sigma-rectum, where microscopic examination
occasionally revealed intraparietal and intraluminal hemorrhages (data
not shown). While disjointed, the stumps were loosely held together by
a short, fibrous, highly vascularized membrane in place of the
mesentery. No gut structure was visible spanning the gap.
Genotyping showed the
midgut phenotype to occur nearly exclusively
in homozygous mutant pups, at a frequency of ~25%. It can thus
account for most of the increased perinatal mortality of this class.
Much rarer cases were observed in heterozygotes (~1.3%), and none
were seen in wt mice.
Growth impairment in MTG8 exon 2-targeted mice.
Of
the offspring of heterozygous crosses surviving past the first 48 h, a number showed impaired growth, becoming progressively more marked
during the subsequent 2 weeks. Typically, pups were 30 to 50% the size
of normal littermates in weight, albeit well proportioned and normally
active, except for the most extreme cases. Mortality was high. The few
surviving mice gradually recovered with age after puberty, while
remaining of below-average weight.
Nearly all affected mice were homozygous mutants. Conversely, all of
the latter showed growth impairment. Thus, the phenotype was strongly
associated with homozygosity for the MTG8 exon 2-null allele.
Upon sacrifice, growth-impaired mice did not show any obvious anomaly
outside the gastrointestinal tract. The intestine, while of reduced
length compared to control littermates, was proportionate to the lower
body weight. However, the gut histology was grossly abnormal,
particularly at the level of the jejunum (Fig. 2C). The intestinal wall
was thinner, largely due to a reduction in the length of the villi,
which also looked highly disorganized, thicker, and fewer in numbers.
Moreover, the lumen was often dilated, probably reflecting a reduced
tone of the muscle layers.
In order to investigate whether the abnormal architecture was
associated with changes in cellular differentiation, sections from
pathological and normal guts were stained for gut cell markers. Of the
four main types of gut epithelial cells, enterocytes can be identified
by the expression of sucrase-isomaltase and goblet and Paneth cells by
a combination of Alcian blue and lectin UEAI staining. Contractile
cells in the tunica muscularis, as well as in perivascular locations,
express
-smooth muscle actin, and ENS cells express
-tubulin III.
As shown in Fig. 3,
all five cell types were present in
homozygous mutant guts, in proportions and locations that were not
significantly different from those of wt littermates.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 3.
Cell lineages and proliferation in the jejunum of
growth-impaired MTG8 exon 2-targeted mice. Jejunal sections
from the mice shown in Fig. 2 were stained for markers of
differentiated and proliferating cells. Sucrase-isomaltase (S/I) is a
brush border enzyme characteristic of enterocytes; UEAI lectin (UEAI)
binds to -linked fucose residues in polysaccharides secreted by
goblet and Paneth cells; -smooth muscle actin ( -smAct) is present
in the muscle layers of the gastrointestinal tract, as well as in
vascular smooth muscle cells and myofibroblasts; -tubulin III
( -tubIII) identifies ENS cells, and PCNA is an antigen associated
with actively cycling cells. A positive reaction (brown color) was
developed by the immunoperoxidase-diaminobenzidine technique, followed
by counterstaining with Gill's hematoxylin. Despite the disruption of
the gut architecture, the rates of cell differentiation and cell
proliferation in the mutant are not significantly different from those
in the control.
|
|
The size of the intestinal villi results from the proliferative
activity of cells in crypts. Quantitation of PCNA-positive, cycling
cells in MTG8 exon 2-targeted and wt littermates (Fig. 3)
does not show any significant difference, indicating that the shorter
villi in the mutants are not the result of decreased epithelial stem
cell activity.
Mouse MTG8 is expressed in the mesoderm of the
developing gut.
While MTG8 has not been reported to be
expressed in the adult gut, the phenotype of MTG8 exon
2-targeted mutants suggested it plays a key role in the
gastrointestinal system. In order to test this hypothesis,
MTG8 expression was studied during development, by staining
heterozygous MTG8Ex2/lacZ embryos for
-galactosidase. Validation of the method was sought in preliminary
experiments on adult tissues, in which the results obtained with the
-galactosidase stain were found to match faithfully those obtained
by RNA analysis in wt mice (data not shown).
At the 26-somite stage, MTG8 is clearly expressed throughout
the primitive gut, albeit at the highest levels in the hindgut (Fig.
4, top panels). Most of the LacZ signal
is localized outside the epithelial layer lining the gut lumen, i.e.,
in the mesodermally derived component.

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 4.
MTG8 expression in the embryonic gut.
Transverse sections through
MTG8Ex2/lacZ-heterozygous and wt embryos at E10
and E14.5, stained for -galactosidase activity as a proxy for
MTG8 expression, are shown. E14.5 sections were
counterstained with eosin. MTG8 is expressed in the
mesodermally, rather than in the endodermally, derived tissue and
becomes restricted, at the later time point, to the outermost gut
layers. fg, foregut; hg, hindgut; da, dorsal aorta.
|
|
This pattern becomes even more obvious at later stages. At E14.5 (Fig.
4, bottom panels), there is strong expression in the outermost gut tube
layers and the contiguous mesentery, whereas almost no signal is
detectable in the epithelium lining the lumen and in the subjacent
lamina propria.
Developmental origin of the gut phenotype in MTG8 exon
2-targeted mice.
In order to define the developmental origin of
the gut phenotype associated with the MTG8 exon 2-null
allele, embryos from heterozygous crosses were collected between E9.5
and E17.5, corresponding to the stages at which most of the critical
gut morphogenetic events occur. Compared to wt littermates, no
significant difference was observed up to E15.5 although, at the latter
time point, the size of the umbilical hernia appeared to be somewhat
smaller than in controls and the complexity of the midgut loops was
reduced (data not shown). However, a disruption of the villi similar
to, albeit less extensive than, that seen in postnatal cases was
clearly apparent at E17.5 (Fig. 5). This
was associated with persistence of the umbilical hernia, normally
disappearing entirely by E16.5. Although preliminary, the data indicate
that the requirement for wt MTG8 in the gut starts in the late stages
of prenatal development.

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 5.
Developmental origin of the gut phenotype in
MTG8 exon 2-targeted mice. Hematoxylin and eosin-stained
transverse sections through the region of the umbilical hernia of
MTG8 exon 2-targeted ( / ) and control (+/+) E17.5 embryos
are shown. In the former, the double-headed arrow indicates the
communication between the abdominal cavity and the umbilical hernia,
which is still prominent, whereas it has normally disappeared at this
stage in control littermates.
|
|
Expression of gut patterning factors in MTG8 exon
2-targeted mutants.
Gut development is known to be controlled by a
number of factors which, as in other systems, can be distinguished into
two classes: signaling factors, mediating cellular interactions, and transcription factors, directly controlling gene activity. The former
includes mesodermally derived Bmp4 and endodermally derived shh/ihh
(39). Among the latter class, in addition to Hox gene products (Hoxd13), knockout experiments have revealed a crucial role
for the D. melanogaster caudal homologue Cdx2 (encoded in the ParaHox cluster) (5), as well as for Fkh6 (belonging
to the forkhead family) (13) and Nkx2-3 (a homeobox gene
product) (25). Since MTG8 is expressed in the
mesoderm of the primitive gut and since its mutation has dramatic
consequences on the gut structure, we sought to determine their
relationship to other gut patterning factors by examining its
expression in MTG8 exon 2-targeted mutants. RNA was
extracted from proximal and distal gut segments of growth-impaired
MTG8Ex2/lacZ-homozygous mice and wt littermates,
and transcript levels were analyzed by nuclease protection.
Representative results are shown in Fig.
6. Despite some occasional minor
differences, there was no consistent change in RNA levels of Bmp2/4,
Cdx1/2, Nkx2-3, or Fkh6 between the null mutant and the wt in either
segment. Thus, the role of MTG8 in the gut is not mediated
through one of the already-identified gut patterning factors.

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 6.
Expression of gut morphogenetic factors in
growth-impaired MTG8 exon 2-targeted mice. S1 protection
analysis of RNA from proximal (je) and distal (co) gut segments from a
P7 MTG8 exon 2-targeted homozygous pup (weight, 2.78 g)
and a control (wt) littermate (weight, 5.98 g) was carried out.
tRNA, negative control for probe hybridization. The probes are
described in Table 1. The top band corresponds to residual undigested
full-length probe. Filled arrows indicate the expected protected
fragment for each probe. For reference purposes, protection by an actin
probe added to the same hybridization mixture is shown at the bottom
(white arrow). The numbers on the left indicate the molecular size
markers in nucleotides. The apparent minor differences with some probes
were inconsistent.
|
|
 |
DISCUSSION |
In order to investigate the function of the MTG8 locus,
we generated a mutant allele, MTG8Ex2/lacZ, in
which part of exon 2 and of the downstream intron have been replaced by
sequences encoding
-galactosidase and neomycin phosphotransferase. The sequence encoded by exon 2, spanning 46 amino acids, is very close
to the proposed alternative amino termini. While alternative splicing
has been observed both 5' and 3', exon 2 has never been found missing
either from wt MTG8 transcripts (20, 40; Calabi, unpublished) or from runx1/MTG8 fusion transcripts arising from the
t(8;21) of AML (30, 35). This suggests that this exon plays a crucial function, although it does not encode any of the four
regions (NHR1 to -4) that are conserved among all MTG8-like polypeptides, and database searches have yet to reveal any significant homology.
Lack of MTG8 polypeptides carrying exon 2-encoded sequences results in
high mortality, either perinatally or associated with significant
growth impairment during the first 2 weeks of life. Most of the early
mortality is due to a massive defect in the gastrointestinal tract. An
abnormal gut structure is also found in growth-impaired mice and is a
plausible cause of the latter phenotype, given its likely effects on
the absorption of nutrients. As in other cases of gene targeting,
variable phenotypic penetrance and/or expression may be explained by
genetic heterogeneity within the strain resulting from targeting and
may indicate the existence of interacting genetic factors. Moreover, a
gene dosage effect is suggested by the occurrence of a similar
phenotype in heterozygous mice, albeit at a much reduced frequency.
Our results indicate that MTG8 has a crucial function in the
gastrointestinal system. While no appreciable expression has been
detected in the adult gut, our data show that the embryonic gut is,
with the heart (data not shown), one of the main sites of expression at
least from E9.5. The highest levels are found in the outer layers, in
contrast to other factors so far found to be expressed in the
developing gut, which are either endodermal (Cdx1 and -2, shh/ihh,
Bmp2, and Tcf4) or primarily restricted to the subendodermal mesoderm
(Nkx2-3, Fkh6, Gli1/Ptc, and Bmp4) (2, 13, 17, 25, 27).
Intriguingly, the Drosophila homologue of MTG8
(nervy) was isolated as a downstream target of Ubx
(9), which is known to play a role in gut patterning in
the fruitfly (3). However, no phenotype is associated with
nervy mutations, and the role of the latter in the fruitfly
remains to be established, as is the potential existence of a
Hox-MTG8 pathway in higher organisms.
The
midgut phenotype shows some analogies to intestinal atresias in
humans, which are generally believed to result from vascular accidents,
although a genetic origin has been implicated in some cases
(31). The extent of the defect largely coincides with the
districts supplied by the superior mesenteric artery. Moreover, while
the latter seems to be properly formed, there is vascular congestion
over the proximal and particularly the distal gastrointestinal stumps,
albeit with no evidence of necrosis. Unlike human cases, however, there
is no proximal atresia, while a peculiar mucosal outgrowth extends from
the duodenal end. There are no remnants of the missing gut segments,
and the mesentery, albeit greatly shortened, shows no gaps. The
contribution of MTG8 mutations to gut defects in humans
remains to be investigated.
The milder phenotype associated with the MTG8 exon 2 knockout has some superficial analogies with those recently described in other mice with targeted disruption of genes involved in gut development. Both Fkh6- and Nkx2-3-null embryos
show delayed formation and slower growth of villi (13,
25). In both cases the changes are apparent from the time of the
initial transition from pseudostratified to columnar gut epithelium,
coincide with alterations in the proliferative compartment, and
correlate with a reduction in the levels of Bmp2 and -4 mRNA,
suggesting that they are mediated via a common signaling pathway. In
Tcf4- and ihh-null mice (17, 27),
which die at or shortly after birth, there is a substantial decrease in
the size of the villi associated with a reduction or, respectively, a
nearly complete absence of proliferating stem cells. Similarly to these
other null mutants, the milder gut phenotype of MTG8 exon
2-targeted mice shows disorganization of the villi, which coexists with
largely normal differentiation of gut cell lineages and is most
pronounced in the proximal intestine (i.e., the jejunum). However,
early midgut morphogenetic events (i.e., the formation of epithelial
ridges) are not affected (data not shown), and cell proliferation is
not reduced. Further proof that the MTG8 function in gut
development and/or differentiation is independent of previously identified pathways is provided by the analysis of patterns of gene
expression in the mutants: Bmp2/4, Cdx1/2, Nkx2-3, and Fkh6 mRNA levels
are essentially unchanged in the MTG8 exon 2 knockout.
We hypothesize that the two distinct phenotypes of MTG8 exon
2 mutant mice represent different degrees of severity of the same
condition, resulting from the lack of a single
MTG8-controlled function. Such function is unlikely to be
required for primary gut morphogenesis, since the gut was fully formed
in a majority of mutants, and no gut anomaly was found in homozygous
mutant embryos up to E15.5. Primary canalization of the gut tube in the
midgut phenotype is also indicated by the finding of meconium in the
rectal stump (data not shown) and by the absence of concomitant abdominal wall defects indicative of a failure in the process of
embryonic folding or ventral midline fusion.
We suggest that MTG8 is required for the maintenance of a
normal gut structure from late embryonic development, since pathologic changes can be clearly detected in the mutants by E17.5. This function
may be related to the blood supply of the midgut, leading in the most
extreme cases to a complete regression (
midgut) and in less severe
cases to dysplasia (causing malabsorption). Rescue of the latter
phenotype may occur due to the postnatal triggering of compensatory
mechanisms, similar to what has been reported in other knockouts. This
hypothesis would be consistent with the localization of MTG8
expression to the outermost layers of the gut, containing the main
submucosal vascular plexuses.
In addition to the gastrointestinal defects, sterility was consistently
observed in the few male null mutants surviving into adulthood. While
the basis of this phenotype remains to be clarified, X-Gal staining in
MTG8Ex2/lacZ heterozygotes shows MTG8
to be mostly expressed by Leydig cells in the adult testis. This
suggests that male sterility in homozygotes, despite apparently normal
testis size and morphology, is due to hormonal insufficiency. Hind limb
paresis and/or paralysis was rarely observed in adult mutant mice. By
X-Gal staining in heterozygotes, we have been unable to detect
MTG8 expression in the spinal cord, peripheral nerves, or
skeletal muscles, and the cause of this phenotype remains to be
investigated. In contrast, insertional inactivation of MTG8
exon 2 is phenotypically silent in the brain, lung, or heart, all major
sites of expression. Histological examination has also so far failed to
reveal any abnormality (data not shown). Thus, the function of
MTG8 in these organs is likely to be at least potentially
redundant, and its absence may be compensated for by an increase in
alternative isoforms and/or by MTG8 paralogues.
Finally, our data do not support a role for MTG8 in
haemopoiesis. Upon X-Gal staining, no significant expression of the
MTG8Ex2/lacZ allele was found either in embryos
or in the main hemopoietic lineages of adult mice (data not shown). The
bone marrow Ly-6A/E+ subpopulation, containing hemopoietic
stem cells, also scored negative. Moreover, no hemopoietic defect was
observed in homozygous mutant mice. These data contrast with the report
of MTG8 expression in human CD34+ cells
(8). Apart from possible species-specific differences, the
latter results may have rather been due to cross-reacting products
encoded by MTG8 paralogues, which are known to be expressed in hemopoietic cells (4, 7, 10). We conclude that the role
(if any) of MTG8 in leukemia may be at least partly related to its abnormal expression in hemopoietic precursors.
 |
ACKNOWLEDGMENTS |
We are particularly grateful to Terence Rabbitts for constant
encouragement and strategic advice. We also thank Vania Cilli for help
in the isolation of mouse MTG8 genomic clones, Dallas Swallow for the gift of the anti-human sucrase-isomaltase monoclonal antibody, Andy Copp and Patrizia Ferretti for comments, and the staff
of the Royal Veterinary College, London, England, for expert mouse husbandry.
This work was supported by MRC PG9311737.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Developmental
Biology Unit, The Institute of Child Health, 30 Guilford St., London WCIN 1EH, United Kingdom. Phone: 44-20-7813-8492. Fax:
44-20-7831-4366. E-mail:
fcalabi{at}hgmp.mrc.ac.uk.
 |
REFERENCES |
| 1.
|
Albright, S. R., and R. Tjian.
2000.
TAFs revisited: more data reveal new twists and confirm old ideas.
Gene
242:1-13[CrossRef][Medline].
|
| 2.
|
Beck, F.,
F. Tata, and K. Chawengsaksophak.
2000.
Homeobox genes and gut development.
Bioessays
22:431-441[CrossRef][Medline].
|
| 3.
|
Bienz, M.
1994.
Homeotic genes and positional signalling in the Drosophila viscera.
Trends Genet.
10:22-26[CrossRef][Medline].
|
| 4.
|
Calabi, F., and V. Cilli.
1998.
CBFA2T1, a gene rearranged in human leukemia, is a member of a multigene family.
Genomics
52:332-341[CrossRef][Medline].
|
| 5.
|
Chawengsaksophak, K.,
R. James,
V. E. Hammond,
F. Kontgen, and F. Beck.
1997.
Homeosis and intestinal tumours in Cdx2 mutant mice.
Nature
386:84-87[CrossRef][Medline].
|
| 6.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 7.
|
Davis, J. N.,
B. J. Williams,
J. T. Herron,
F. J. Galiano, and S. Meyers.
1999.
ETO-2, a new member of the ETO-family of nuclear proteins.
Oncogene
18:1375-1383[CrossRef][Medline].
|
| 8.
|
Erickson, P. F.,
G. Dessev,
R. S. Lasher,
G. Philips,
M. Robinson, and H. A. Drabkin.
1996.
ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors implications for t(8;21) leukemogenesis and monitoring residual disease.
Blood
88:1813-1823[Abstract/Free Full Text].
|
| 9.
|
Feinstein, P. G.,
K. Kornfeld,
D. S. Hogness, and R. S. Mann.
1995.
Identification of homeotic target genes in Drosophila melanogaster including nervy, a protooncogene homolog.
Genetics
140:573-586[Abstract].
|
| 10.
|
Fracchiolla, N. S.,
G. Colombo,
P. Finelli,
A. T. Maiolo, and A. Neri.
1998.
EHT, a new member of the MTG8/ETO gene family, maps on 20q11 region and is deleted in acute myeloid leukemias.
Blood
92:3481-3484[Free Full Text].
|
| 11.
|
Gelmetti, V.,
J. S. Zhang,
M. Fanelli,
S. Minucci,
P. G. Pelicci, and M. A. Lazar.
1998.
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.
Mol. Cell. Biol.
18:7185-7191[Abstract/Free Full Text].
|
| 12.
|
Green, F. R.,
P. Greenwell,
L. Dickson,
B. Griffiths,
J. Noades, and D. M. Swallow.
1988.
Expression of the ABH, Lewis and related antigens on the glycoproteins of the jejunal brush border, p. 119-153.
In
J. R. Harris (ed.), Subcellular biochemistry, vol. 12. Plenum Publishing, New York, N.Y.
|
| 13.
|
Kaestner, K. H.,
D. G. Silberg,
P. G. Traber, and G. Schutz.
1997.
The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation.
Genes Dev.
11:1583-1595[Abstract/Free Full Text].
|
| 14.
|
Kagoshima, H.,
K. Shigesada,
M. Satake,
Y. Ito,
H. Miyoshi,
M. Ohki,
M. Pepling, and P. Gergen.
1993.
The runt domain identifies a new family of heteromeric transcriptional regulators.
Trends Genet.
9:338-341[CrossRef][Medline].
|
| 15.
|
Kitabayashi, I.,
K. Ida,
F. Morohoshi,
A. Yokoyama,
N. Mitsuhashi,
K. Shimizu,
N. Nomura,
Y. Hayashi, and M. Ohki.
1998.
The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.
Mol. Cell. Biol.
18:846-858[Abstract/Free Full Text].
|
| 16.
|
Komori, T.,
H. Yagi,
S. Nomura,
A. Yamaguchi,
K. Sasaki,
K. Deguchi,
Y. Shimizu,
R. T. Bronson,
Y. H. Gao,
M. Inada,
M. Sato,
R. Okamoto,
Y. Kitamura,
S. Yoshiki, and T. Kishimoto.
1997.
Targeted disruption of CBFA1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.
Cell
89:755-764[CrossRef][Medline].
|
| 17.
|
Korinek, V.,
N. Barker,
P. Moerer,
E. van Donselaar,
G. Huls,
P. J. Peters, and H. Clevers.
1998.
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.
Nat. Genet.
19:379-383[CrossRef][Medline].
|
| 18.
|
Le, X. F.,
D. Claxton,
S. Kornblau,
Y. H. Fan,
Z. M. Mu, and K. S. Chang.
1998.
Characterization of the ETO and AML1-ETO proteins involved in the 8;21 translocation in acute myelogenous leukemia.
Eur. J. Haematol.
60:217-225[Medline].
|
| 19.
|
Lutterbach, B.,
J. J. Westendorf,
B. Linggi,
A. Patten,
M. Moniwa,
J. R. Davie,
K. D. Huynh,
V. J. Bardwell,
R. M. Lavinsky,
M. G. Rosenfeld,
C. Glass,
E. Seto, and S. W. Hiebert.
1998.
ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.
Mol. Cell. Biol.
18:7176-7184[Abstract/Free Full Text].
|
| 20.
|
Miyoshi, H.,
T. Kozu,
K. Shimizu,
K. Enomoto,
N. Maseki,
Y. Kaneko,
N. Kamada, and M. Ohki.
1993.
The t(8;21) translocation in acute myeloid-leukemia results in production of an AML1-MTG8 fusion transcript.
EMBO J.
12:2715-2721[Medline].
|
| 21.
|
Miyoshi, H.,
K. Shimizu,
T. Kozu,
N. Maseki,
Y. Kaneko, and M. Ohki.
1991.
t(8;21) breakpoints on chromosome-21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.
Proc. Natl. Acad. Sci. USA
88:10431-10434[Abstract/Free Full Text].
|
| 22.
|
Mundlos, S.,
F. Otto,
C. Mundlos,
J. B. Mulliken,
A. S. Aylsworth,
S. Albright,
D. Lindhout,
W. G. Cole,
W. Henn,
J. Knoll,
M. J. Owen,
R. Mertelsmann,
B. U. Zabel, and B. R. Olsen.
1997.
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.
Cell
89:773-779[CrossRef][Medline].
|
| 23.
|
Okuda, T.,
J. Vandeursen,
S. W. Hiebert,
G. Grosveld, and J. R. Downing.
1996.
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
Cell
84:321-330[CrossRef][Medline].
|
| 24.
|
Otto, F.,
A. P. Thornell,
T. Crompton,
A. Denzel,
K. C. Gilmour,
I. R. Rosewell,
G. Stamp,
R. Beddington,
S. Mundlos,
B. R. Olsen,
P. B. Selby, and M. J. Owen.
1997.
CBFA1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.
Cell
89:765-771[CrossRef][Medline].
|
| 25.
|
Pabst, O.,
R. Zweigerdt, and H. H. Arnold.
1999.
Targeted disruption of the homeobox transcription factor Nkx2-3 in mice results in postnatal lethality and abnormal development of small intestine and spleen.
Development
126:2215-2225[Abstract].
|
| 26.
|
Rabbitts, T. H.
1999.
Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation why are these functions targeted?
J. Pathol.
187:39-42[CrossRef][Medline].
|
| 27.
|
Ramalho-Santos, M.,
D. A. Melton, and A. P. McMahon.
2000.
Hedgehog signals regulate multiple aspects of gastrointestinal development.
Development
127:2763-2772[Abstract].
|
| 28.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, New York, N.Y.
|
| 29.
|
Sanes, J. R.,
J. L. Rubenstein, and J. F. Nicolas.
1986.
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
EMBO J.
5:3133-3142[Medline].
|
| 30.
|
Saunders, M. J.,
K. Tobal,
S. Keeney, and J. Yin.
1996.
Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid-leukemia with t(8;21) irrespective of disease phase.
Leukemia
10:1139-1142[Medline].
|
| 31.
|
Skandalakis, J. E.,
S. W. Gray,
R. Ricketts, and D. D. Richardson.
1994.
The small intestine, p. 200-212.
In
J. E. Skandalakis, and S. W. Gray (ed.), Embryology for surgeons, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
|
| 32.
|
Song, W. J.,
M. G. Sullivan,
R. D. Legare,
S. Hutchings,
X. Tan,
D. Kufrin,
J. Ratajczak,
I. C. Resende,
C. Haworth,
R. Hock,
M. Loh,
C. Felix,
D. C. Roy,
L. Busque,
D. Kurnit,
C. Willman,
A. M. Gewirtz,
N. A. Speck,
J. H. Bushweller,
F. P. Li,
K. Gardiner,
M. Poncz,
J. M. Maris, and D. G. Gilliland.
1999.
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.
Nat. Genet.
23:166-175[CrossRef][Medline].
|
| 33.
|
Speck, N. A.,
T. Stacy,
Q. Wang,
T. North,
T. L. Gu,
J. Miller,
M. Binder, and M. MarinPadilla.
1999.
Core-binding factor: a central player in hematopoiesis and leukemia.
Cancer Res.
59:S1789-S1793.
|
| 34.
|
Thomas, K. R., and M. R. Capecchi.
1987.
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.
Cell
51:503-512[CrossRef][Medline].
|
| 35.
|
Tighe, J. E., and F. Calabi.
1994.
Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative(8) chromosome in the t(8;21) of acute myeloid-leukemia M2.
Blood
84:2115-2121[Abstract/Free Full Text].
|
| 36.
|
Wang, J. X.,
T. Hoshino,
R. L. Redner,
S. Kajigaya, and J. M. Liu.
1998.
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
Proc. Natl. Acad. Sci. USA
95:10860-10865[Abstract/Free Full Text].
|
| 37.
|
Wang, Q.,
T. Stacy,
M. Binder,
M. Marinpadilla,
A. H. Sharpe, and N. A. Speck.
1996.
Disruption of the CBFA2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.
Proc. Natl. Acad. Sci. USA
93:3444-3449[Abstract/Free Full Text].
|
| 38.
|
Warren, A. J.,
W. H. Colledge,
M. B. Carlton,
M. J. Evans,
A. J. Smith, and T. H. Rabbitts.
1994.
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.
Cell
78:45-57[CrossRef][Medline].
|
| 39.
|
Wells, J. M., and D. A. Melton.
1999.
Vertebrate endoderm development.
Annu. Rev. Cell. Dev. Biol.
15:393-410[CrossRef][Medline].
|
| 40.
|
Wolford, J. K., and M. Prochazka.
1998.
Structure and expression of the human MTG8/ETO gene.
Gene
212:103-109[CrossRef][Medline].
|
Molecular and Cellular Biology, August 2001, p. 5658-5666, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5658-5666.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chyla, B. J., Moreno-Miralles, I., Steapleton, M. A., Thompson, M. A., Bhaskara, S., Engel, M., Hiebert, S. W.
(2008). Deletion of Mtg16, a Target of t(16;21), Alters Hematopoietic Progenitor Cell Proliferation and Lineage Allocation. Mol. Cell. Biol.
28: 6234-6247
[Abstract]
[Full Text]
-
Okumura, A. J., Peterson, L. F., Okumura, F., Boyapati, A., Zhang, D.-E.
(2008). t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression. Blood
112: 1392-1401
[Abstract]
[Full Text]
-
Kumar, R., Cheney, K. M., McKirdy, R., Neilsen, P. M., Schulz, R. B., Lee, J., Cohen, J., Booker, G. W., Callen, D. F.
(2008). CBFA2T3-ZNF652 Corepressor Complex Regulates Transcription of the E-box Gene HEB. J. Biol. Chem.
283: 19026-19038
[Abstract]
[Full Text]
-
Moore, A. C., Amann, J. M., Williams, C. S., Tahinci, E., Farmer, T. E., Martinez, J. A., Yang, G., Luce, K. S., Lee, E., Hiebert, S. W.
(2008). Myeloid Translocation Gene Family Members Associate with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription. Mol. Cell. Biol.
28: 977-987
[Abstract]
[Full Text]
-
Kumar, R., Manning, J., Spendlove, H. E., Kremmidiotis, G., McKirdy, R., Lee, J., Millband, D. N., Cheney, K. M., Stampfer, M. R., Dwivedi, P. P., Morris, H. A., Callen, D. F.
(2006). ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription. Mol Cancer Res
4: 655-665
[Abstract]
[Full Text]
-
Linggi, B., Carpenter, G.
(2006). ErbB-4 s80 Intracellular Domain Abrogates ETO2-dependent Transcriptional Repression. J. Biol. Chem.
281: 25373-25380
[Abstract]
[Full Text]
-
Amann, J. M., Chyla, B. J. I., Ellis, T. C., Martinez, A., Moore, A. C., Franklin, J. L., McGhee, L., Meyers, S., Ohm, J. E., Luce, K. S., Ouelette, A. J., Washington, M. K., Thompson, M. A., King, D., Gautam, S., Coffey, R. J., Whitehead, R. H., Hiebert, S. W.
(2005). Mtgr1 Is a Transcriptional Corepressor That Is Required for Maintenance of the Secretory Cell Lineage in the Small Intestine. Mol. Cell. Biol.
25: 9576-9585
[Abstract]
[Full Text]
-
Lausen, J., Cho, S., Liu, S., Werner, M. H.
(2004). The Nuclear Receptor Co-repressor (N-CoR) Utilizes Repression Domains I and III for Interaction and Co-repression with ETO. J. Biol. Chem.
279: 49281-49288
[Abstract]
[Full Text]
-
Rochford, J. J., Semple, R. K., Laudes, M., Boyle, K. B., Christodoulides, C., Mulligan, C., Lelliott, C. J., Schinner, S., Hadaschik, D., Mahadevan, M., Sethi, J. K., Vidal-Puig, A., O'Rahilly, S.
(2004). ETO/MTG8 Is an Inhibitor of C/EBP{beta} Activity and a Regulator of Early Adipogenesis. Mol. Cell. Biol.
24: 9863-9872
[Abstract]
[Full Text]
-
Zhang, J., Kalkum, M., Yamamura, S., Chait, B. T., Roeder, R. G.
(2004). E Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein. Science
305: 1286-1289
[Abstract]
[Full Text]
-
Chevallier, N., Corcoran, C. M., Lennon, C., Hyjek, E., Chadburn, A., Bardwell, V. J., Licht, J. D., Melnick, A.
(2004). ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood
103: 1454-1463
[Abstract]
[Full Text]
-
Barseguian, K., Lutterbach, B., Hiebert, S. W., Nickerson, J., Lian, J. B., Stein, J. L., van Wijnen, A. J., Stein, G. S.
(2002). Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Proc. Natl. Acad. Sci. USA
99: 15434-15439
[Abstract]
[Full Text]